Rx drug information, pharmaceutical research, clinical trials, news, and more
Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. [1999.11]
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. [1989.07]
Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream. [1988.09]
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. [2005.12]
Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation. [1994.11]
Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. [1993.11]
Severe reversible thrombocytopenia resulting from butoconazole cream. [1990.02]
Effect of butoconazole nitrate cream and wax insert on the barrier property of contraceptive devices. [1988.04]
Vaginal Candida parapsilosis: pathogen or bystander? [2005.03]
New York State primary care physicians' attitudes to community pharmacists' clinical services. [1996.07.08]
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. [1991.10]
Patient acceptance of prefilled disposable vaginal applicator. [1988.04]
Three-day treatment of vulvovaginal candidiasis. [1988.04]
All Rights reserved - Copyright DrugLib.com, 2006-2017